Recall Register

Food, drugs, devices

Drug recall: Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle, Distribut

FDA enforcement event 91621 · Class I · initiated 30 Jan 2023 · status Ongoing

DrugVoluntary: Firm initiated4 product recordsChennai, N/A

Global Pharma Healthcare Private Limited (Chennai, N/A) initiated this drug recall on 30 Jan 2023; FDA lists 4 product records under event 91621, classified Class I.

FDA defines Class I as a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. 15% of the 281 drug enforcement events initiated in 2023 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Global Pharma Healthcare Private Limited has 2 enforcement events on this register, with a median of 4 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Global Pharma Healthcare Private Limited, Chennai, N/A, India.

Reason for recall

"CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated."

Distribution

"Product was distributed to two distributors who further distributed Nationwide in the USA."

Product records

Recall numberProductQuantityClassStatusReport date
D-0919-2023Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle, Distributed by. EzriCare, LLC, Lakewood, NJ, NDC 79503-0101-15.400,008 bottles total for all productsClass IOngoing19 Jul 2023
D-0920-2023Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle, Distributed by. EzriCare, LLC, Lakewood, NJ, NDC 79503-0101-15.400,008 bottles total for all productsClass IIOngoing19 Jul 2023
D-0921-2023Delsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1%, 1/2 fl oz (15 ml) bottle, Distributed By: Delsam Pharma Llc, Bronx, New York 10467, NDC 72570 121 15.400,008 bottles total for all productsClass IOngoing19 Jul 2023
D-0922-2023Delsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1%, 1/2 fl oz (15 ml) bottle, Distributed By: Delsam Pharma Llc, Bronx, New York 10467, NDC 72570 121 15.400,008 bottles total for all productsClass IIOngoing19 Jul 2023

Context

15%of 2023 drug events are Class I281 events that year
4product records in this eventfirm median: 4
2events on this register for the firm

Other enforcement events for Global Pharma Healthcare Private Limited

InitiatedProduct (first record)TypeClassRecords
24 Feb 2023Delsam Pharma's Artificial Eye Ointment (Mineral Oil 15%, White Petrolatum 83%), 3.5 grams (1/8 oz.) tube, Distributed B (91768)DrugClass I1

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated."

What does Class I mean?

FDA classifies recalls by relative degree of health hazard. Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

Where was the product distributed?

FDA's distribution pattern field reads: "Product was distributed to two distributors who further distributed Nationwide in the USA."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.